ELAN
Elanco Animal Health Incorporated
Pharmaceutical Preparations- 売上
- $4.7bn
- 時価総額
- $13.1bn
株価 $26.46 · 100株 2,646円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $4.4bn | $4.4bn | $4.7bn |
| 成長率 | — | 0.5% | 6.2% |
| 総利益 | $2.5bn | $2.4bn | $2.6bn |
| 総利益率 | 56.3% | 54.9% | 55.0% |
| 販管費 | $1.3bn | $1.3bn | $1.4bn |
| 販管費率 | 29.1% | 29.6% | 30.3% |
| 営利 | — | — | — |
| 営利率 | — | — | — |
| 純利益 | ▲$1.2bn | $338m | ▲$232m |
| PBR | 2.1 | 2.1 | 2.0 |
| PSR | 3.0 | 2.9 | 2.8 |
| PGPR | 5.3 | 5.4 | 5.0 |
| PER | — | 39 | — |
| ﾈｯﾄｷｬｯｼｭ | ▲$5.4bn | ▲$3.9bn | ▲$3.5bn |
| EV/EBITDA | — | — | — |
| Rule of 40 | — | — | — |
| セールス効率 | — | ▲172% | 135% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）